News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,588 Results
Type
Article (87845)
Company Profile (824)
Press Release (779905)
Multimedia
Podcasts (190)
Webinars (28)
Section
Business (233197)
Career Advice (4144)
Deals (39856)
Drug Delivery (145)
Drug Development (91390)
Employer Resources (203)
FDA (18372)
Job Trends (17416)
News (397795)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (179)
Alzheimer's disease (1776)
Antibody-drug conjugate (ADC) (324)
Approvals (18530)
Artificial intelligence (601)
Autoimmune disease (147)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (155)
Brain cancer (63)
Breast cancer (638)
Cancer (4856)
Cardiovascular disease (426)
Career advice (3566)
Career pathing (40)
CAR-T (298)
CDC (59)
Celiac Disease (1)
Cell therapy (805)
Cervical cancer (37)
Clinical research (76813)
Collaboration (1700)
Company closure (5)
Compensation (1111)
Complete response letters (69)
COVID-19 (2984)
CRISPR (94)
C-suite (807)
Cystic fibrosis (151)
Data (6076)
Decentralized trials (2)
Denatured (70)
Depression (139)
Diabetes (518)
Diagnostics (7199)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (291)
Drug pricing (213)
Drug shortages (36)
Duchenne muscular dystrophy (231)
Earnings (99953)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134866)
Executive appointments (1019)
FDA (21392)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (24)
Funding (1499)
Gene editing (205)
Generative AI (62)
Gene therapy (649)
GLP-1 (1103)
Government (5431)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (57)
Huntington's disease (47)
IgA nephropathy (85)
Immunology and inflammation (283)
Immuno-oncology (47)
Indications (80)
Infectious disease (3264)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (232)
Interviews (816)
IPO (17949)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (654)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (662)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (796)
MASH (170)
Medical device (14996)
Medtech (15040)
Mergers & acquisitions (22930)
Metabolic disorders (1347)
Multiple sclerosis (156)
NASH (23)
Neurodegenerative disease (335)
Neuropsychiatric disorders (92)
Neuroscience (3039)
NextGen: Class of 2026 (7706)
Non-profit (5107)
Now hiring (62)
Obesity (648)
Opinion (329)
Ovarian cancer (160)
Pain (195)
Pancreatic cancer (219)
Parkinson's disease (287)
Partnered (38)
Patents (486)
Patient recruitment (445)
Peanut (60)
People (66769)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23736)
Phase II (33324)
Phase III (25130)
Pipeline (4438)
Policy (325)
Postmarket research (3554)
Preclinical (10678)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (842)
Real estate (7437)
Recruiting (80)
Regulatory (28786)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (26)
RNA editing (17)
RSV (82)
Schizophrenia (156)
Series A (250)
Series B (186)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4331)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (97)
The Weekly (118)
Vaccines (1122)
Venture capital (89)
Weight loss (447)
Women's health (82)
Worklife (21)
Date
Today (213)
Last 7 days (878)
Last 30 days (2062)
Last 365 days (33373)
2026 (899)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1289)
Alabama (86)
Alaska (7)
Arizona (336)
Arkansas (14)
Asia (51450)
Australia (9031)
California (11167)
Canada (3235)
China (1109)
Colorado (468)
Connecticut (488)
Delaware (338)
Europe (118222)
Florida (1634)
Georgia (356)
Hawaii (3)
Idaho (68)
Illinois (928)
India (64)
Indiana (530)
Iowa (23)
Japan (408)
Kansas (131)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1425)
Massachusetts (8277)
Michigan (348)
Minnesota (643)
Mississippi (6)
Missouri (136)
Montana (35)
Nebraska (28)
Nevada (121)
New Hampshire (83)
New Jersey (3036)
New Mexico (33)
New York (2969)
North Carolina (1569)
North Dakota (10)
Northern California (5304)
Ohio (341)
Oklahoma (22)
Oregon (54)
Pennsylvania (2243)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4298)
Tennessee (172)
Texas (1767)
United States (40502)
Utah (333)
Vermont (1)
Virginia (280)
Washington D.C. (85)
Washington State (940)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 868,588 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie
Rumors of a Revolution buyout come as the industry gears up for one of its biggest trade conferences, where observers expect many such deals to be announced.
January 9, 2026
·
1 min read
·
Tristan Manalac
Press Releases
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
January 9, 2026
·
3 min read
Press Releases
Alligator Bioscience to Present New OPTIMIZE-1 Data on Mitazalimab at ASCO Gastrointestinal Cancers Symposium 2026
January 9, 2026
·
2 min read
Press Releases
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
January 9, 2026
·
4 min read
Press Releases
Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
January 9, 2026
·
6 min read
Press Releases
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
January 9, 2026
·
5 min read
Press Releases
Innovent’s Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
January 9, 2026
·
8 min read
Press Releases
MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche
January 9, 2026
·
3 min read
Press Releases
FineHeart Secures €83 Million to Support Its Growth and Establish Itself as a Future European Leader in Active Implantable Medical Devices (AIMDs)
January 9, 2026
·
4 min read
Press Releases
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 8, 2026
January 9, 2026
·
1 min read
1 of 86,859
Next
